medicare coverage of glp 1 to cover GLP-1 weight loss drugs for $50/month Medicare just made one of

For the first time, Medicare will cover GLP-1s for obesity-related weight loss, without any other medical conditions

Article 6 mins Outsourced Chief Investment Officer: The Key to Navigating Volatility In a volatile climate, institutional investors are turning to outsourced chief investment officers to conquer administrative, regulatory and market challenges

While previously not licensed for younger patients, Saxenda is now approved in the UK for adolescents aged 12 to less than 18 years with a body weight above 60 kg and obesity (BMI corresponding to 30 kg/m for adults), under specific criteria

doi: 10.1186/1475-2840-10-109

Novo Nordisk initially developed the first GLP-1 RA, liraglutide, as a type-2 diabetes treatment